Eydenzelt (aflibercept-boav)
Biosimilar
- Region
- 🇺🇸 US
- Active substance
- aflibercept-boav
- Company
- Celltrion Inc
- Status
- Approved
- FDA approval
- Thu 02 Oct 2025
- Designations
- Biosimilar
- Application
- BLA761377
- Official record
- www.accessdata.fda.gov
Regulatory milestones
No milestones recorded in the last year.
Follow Eydenzelt
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.